PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Symptom | C0021400|influenza |
| Sentences | 10 |
| PubMedID- 22577464 | The observation of humoral responses after influenza vaccination in patients with rheumatoid arthritis treated with japanese oriental (kampo) medicine: an observational study. |
| PubMedID- 22887851 | Objectives: we assessed the influence of tocilizumab (tcz), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following influenza vaccination in patients with rheumatoid arthritis (ra). |
| PubMedID- 19246078 | The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. |
| PubMedID- 21859696 | Reduced seroprotection after pandemic h1n1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. |
| PubMedID- 22949223 | Abatacept and reduced immune response to pandemic 2009 influenza a/h1n1 vaccination in patients with rheumatoid arthritis. |
| PubMedID- 22999900 | influenza h1n1 infection in a patient with rheumatoid arthritis treated with tocilizumab. |
| PubMedID- 21763385 | Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis b vaccines among persons 15-59 years of age. |
| PubMedID- 26425339 | Extracellular il-33 has also been detected in human blood and synovial fluids in pathological conditions , where cells have been damaged (during rheumatoid arthritis or infection with influenza virus, respectively) and in mouse peritoneal and bronchoalveolar lavage fluid . |
| PubMedID- 24445384 | The objective of this observational study is to determine characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis (ra). |
| PubMedID- 26343963 | Children receiving vaccines on schedule, at one year of age, had a lower rate of seizure compared to those receiving the vaccines later in the second year of life .risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis b vaccines among persons 15–59 years of age. |
Page: 1